Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Does The Smart Money Think of These Two Retailers in the Spotlight?

Page 1 of 2

SUPERVALU INC. (NYSE:SVUand Nordstrom, Inc. (NYSE:JWN) are in the news on the back of separate events. SUPERVALU CEO Sam Duncan has announced that he will retire on February 29, 2016 after three years on the job, while Nordstrom announced a one-time special dividend of $4.85 per share and an additional $1 billion in authorized share buybacks after closing the sale of its credit card portfolio to TD Bank U.S.A. for $1.8 billion in net proceeds. Shares of SUPERVALU have been quiet while shares of Nordstrom have rallied more than 3.5% in after hours trading on Thursday. Let’s take a closer look at the two companies and see if the smart money agrees with the market on any of them.


We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 118% since then and outperformed the S&P 500 Index by around 60 percentage points (see more details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

Follow Supervalu Inc (NYSE:SVU)
Trade (NYSE:SVU) Now!


“SUPERVALU is a terrific organization and we have accomplished a great deal together during the past two and one-half years, I have thoroughly enjoyed working with our employees and thank them for all of their hard work and dedication. I am also looking forward to finishing the year strong and continuing to drive sales and cash through my remaining time at the Company, as well as providing time and support to ensure a smooth transition for my successor. After 46 years in the grocery and retail business, this is a bittersweet moment, but I am also excited by the opportunity to have more time for my family and personal interests following my retirement.”

Duncan’s successor will have his work cut out for him. Shares of the grocer are down 27% year to date as investors fret over impending internet competition and weak sector sales trends. SUPERVALU’s saving grace could be the potential spin off of its Save-A-Lot chain, which many investors think will unlock substantial shareholder value.  It is unclear whether SUPERVALU will spin off Save-A-Lot before Duncan retires, however.

Hedge funds are divided on SUPERVALU INC. (NYSE:SVU). Of the around 730 elite funds we track, 38 investors held stakes with an aggregate value of $394.25 million (representing 18.40% of the float) at the end of June, versus 36 funds and $580 million respectively on March 31. Conan Laughlin‘s North Tide Capital increased its position by 79% to 12.5 million shares, while David Shaw’s D. E. Shaw raised its stake by 21% to 6.32 million shares. Joel Greenblatt’s Gotham Asset Management trimmed its position by 5% to 5.58 million shares and David Harding’s Winton Capital Management cut its holdings by 37% to 1.45 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!